Acuta Capital Partners, LLC Axsome Therapeutics, Inc. Transaction History

Acuta Capital Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$55.91 - $81.44 $335,460 - $488,640	-6,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $1.09 Million - $1.43 Million	-16,500 Reduced 73.33%	6,000 $489,000
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $4.61 Million - $5.79 Million	-67,500 Reduced 75.0%	22,500 $1.6 Million
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $10.9 Million - $21.6 Million	-218,500 Reduced 70.83%	90,000 $7.41 Million
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $12.3 Million - $30.3 Million	-299,000 Reduced 49.22%	308,500 $18.1 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $1.42 Million - $9.03 Million	85,000 Added 16.27%	607,500 $62.8 Million
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $1.72 Million - $2.48 Million	85,000 Added 19.43%	522,500 $10.6 Million
Q2 2019 Aug 14, 2019	BUY	$13.46 - $25.75 $5.89 Million - $11.3 Million	437,500 New	437,500 $11.3 Million

288

40.4M

365K

428K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.84B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.